
Keywords: فاکتور XIII; A/C; oral anticoagulants; APC; activated protein C; BMI; Body Mass Index; CRP; C-reactive protein; DVT; deep vein thrombosis; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; FXIII; Factor XIII; HI; healthy individuals; IQR